A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of JTK-853 Administered for Two Weeks in Healthy Subjects
Latest Information Update: 22 Nov 2011
At a glance
- Drugs JTK 853 (Primary) ; Ketoconazole
- Indications Hepatitis C; Mycoses
- Focus Adverse reactions
- 22 Nov 2011 New trial record